Full Year Results

Source: RNS
RNS Number : 2924S
Halma PLC
13 June 2024
 

HALMA plc

 

FULL YEAR RESULTS 2024

 

Halma, the global group of life-saving technology companies focused on growing a safer, cleaner and healthier future for everyone, every day, today announces its full year results for the 12 months to 31 March 2024 which are available at: http://www.rns-pdf.londonstockexchange.com/rns/2924S_1-2024-6-13.pdf.

 

Halma's results, together with other information about Halma, will be available on its corporate website, www.halma.com, and the results have been submitted in full unedited text to the Financial Conduct Authority's National Storage Mechanism and will shortly be available for inspection at National Storage Mechanism | FCA.

 

The webcast of the results presentation will be available on the Halma website later today: www.halma.com

 

 

Dividends

 

The Board is recommending a 7% increase in the final dividend to 13.20p per share (2023: 12.34p per share). Together with the 8.41p per share interim dividend, this will give a total dividend per share of 21.61p (2023: 20.20p).

 

The final dividend for the financial year ended 31 March 2024 is subject to approval by shareholders at the Annual General Meeting on 25 July 2024 and, if approved, will be paid on 16 August 2024 to shareholders on the register at 12 July 2024.

 

The Company offers a Dividend Reinvestment Plan ('DRIP') to enable shareholders to elect to have their cash dividends reinvested in Halma plc shares. Shareholders who wish to opt for the DRIP for the forthcoming final dividend should return a DRIP mandate form to the Company's Registrar no later than 26 July 2024.

 

Financial calendar



Ex-dividend date for 2024 final dividend

Thursday 11 July 2024

Record date for 2024 final dividend

Friday 12 July 2024

Annual General Meeting

Thursday 25 July 2024

Final date for DRIP election

Friday 26 July 2024

Payment date

Friday 16 August 2024

 

 

 


For further information, please contact:

Halma plc
Marc Ronchetti, Group Chief Executive
Steve Gunning, Chief Financial Officer

Charles King, Head of Investor Relations

Clayton Hirst, Director of Corporate Affairs

 

+44 (0)1494 721 111

 

+44 (0)7776 685948

+44 (0)7834 796 013

MHP
Oliver Hughes/Rachel Farrington/Ollie Hoare

 

+44 (0)20 3128 8100


 

NOTE TO EDITORS

 

1.

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:

 


·      Safety

Protecting people's safety and the environment as populations grow, and enhancing worker safety.

 


·      Environment

Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.

 


·      Health

 

 

Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.

 

 


Halma employs over 8,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

 

Halma has been named as one of Britain's Most Admired Companies for the past six years.

 

2.

You can view or download copies of this announcement and the latest Half Year and Annual Reports from the website at www.halma.com or request free printed copies by contacting halma@halma.com.

 



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSGUGDLCXBDGSX